KRYSbenzinga

Krystal Biotech Secures Positive CHMP Opinion For VYJUVEK For Treatment Of Dystrophic Epidermolysis Bullosa

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on February 28, 2025 by benzinga

    Krystal Biotech Secures Positive CHMP Opinion For VYJUVEK For Treatment Of Dystrophic Epidermolysis Bullosa | KRYS Stock News | Candlesense